Free Shipping $0.00 to free ground
Ground $99
2-Day $150
Overnight $399
// Federal Docket HHS-OASH-2026-0232 · DEA-1570

The Federal Comment Window on 7-OH Closes July 31

The DEA has published a notice of intent to temporarily schedule 7-hydroxymitragynine. Before any rule takes effect, federal law gives you the right to be heard — and public comments have changed outcomes before. This tool helps you write your own comment in a few minutes and send it to the federal docket and your own representatives. We never submit anything for you.

Public comments close — July 31, 2026
--Days
--Hrs
--Min
--Sec
HHS Request for Information · regulations.gov
Earliest possible DEA order — Aug 5, 2026
--Days
--Hrs
--Min
--Sec
Earliest date an order could issue — not a scheduled ban date.
JUL 1, 2026
DEA announces intent to schedule 7-OH
✓ DONE
JUL 6, 2026
Notices published in the Federal Register
✓ DONE
JUL 31, 2026
Public comment period closes
AUG 5, 2026
Earliest date a temporary order could issue
○ PENDING

What Is Happening

In July 2026, the U.S. Drug Enforcement Administration published a notice of intent (Docket DEA-1570) to temporarily place 7-hydroxymitragynine (7-OH) into Schedule I for products above 0.050% concentration or 1.00 mg per article. A companion notice covers mitragynine pseudoindoxyl, MGM-15, and MGM-16.

Separately, the U.S. Department of Health and Human Services opened a Request for Information — docket HHS-OASH-2026-0232 — inviting public input. The comment deadline is July 31, 2026. A notice of intent is not a final rule; the earliest a temporary order could take effect is August 5, 2026.

Public Comments Have Changed the Outcome Before

In August 2016, the DEA published a notice of intent to temporarily schedule kratom's primary alkaloids. What followed was one of the largest public responses to a scheduling notice on record — tens of thousands of comments and letters from members of Congress. In October 2016, the DEA withdrew its notice of intent and opened a public comment period instead. That reversal happened because people participated in the process the law provides. The same process is open right now.

Build Your Comment — Then Reach Everyone Who Should Hear It

Answer a few quick questions and this tool assembles a personal comment in your own voice — no two come out the same, because agencies discount copy-paste form letters. Then it finds your senators and House representative so you can send the same message where it counts most. Everything stays on your device; you press every send button yourself.

1 Your experience 2 Your comment 3 Reach your reps (optional)

Pick the labeled range closest to a typical serving — used only to make your comment specific. The DEA’s proposed cap is just 1 mg per product, far below any real tablet.

Helps show what a ban would push people back toward. Pick any that apply.

Prescription opioids Fentanyl or heroin Methadone / Suboxone Tramadol / codeine Plain-leaf kratom OTC pain relievers Alcohol Nothing — went without
Stayed the sameGone downGone up
NeverOnceMore than once

Two to four sentences in your voice matter more than anything else.

Signs your comment. Name is optional — you can file anonymously if you prefer.

What to Say — In Your Own Words

Write your own comment. Agencies weigh substantive, individual comments far more heavily than identical form letters. Three angles to build from:

  • As a consumer

    Explain, factually, what access means to you and why you choose lab-tested, age-gated products from transparent vendors. Ask for regulation with standards rather than scheduling.

  • As a business owner

    Describe your business concretely — employees, taxes paid, compliance practices you follow — and what an early-August effective date would mean.

  • On testing standards

    Argue that published ISO-17025 lab results, mg caps, accurate labeling, and 21+ verification address safety directly — and that scheduling removes those controls.

More Ways to Be Heard

Our Position: Regulate, Don't Ban

Favor'd Alkz supports real standards for this industry: 21+ age verification on every sale, ISO-17025 accredited, lot-matched certificates of analysis, mg caps per serving, and honest labeling. We publish the COA for every batch we sell — anyone can read them on our lab results page. Scheduling doesn't create standards; it removes the transparent operators who follow them. That is the case we are making in the federal record, and we invite you to make yours.

Frequently Asked Questions

Is 7-OH already illegal?
No. The DEA has published a notice of intent — not a final rule. The earliest possible federal effective date is August 5, 2026. State and local laws vary, so check the rules where you live.
Will my comment be public?
Yes. Comments submitted to regulations.gov are published in the public docket, generally including any name or information you provide. Don't include anything you wouldn't want public.
Does this tool send anything for me?
No. It assembles your comment and finds your representatives, but you copy and submit it yourself — on regulations.gov and on each official's own contact form. You stay in control of every send.
What happens after July 31?
The comment period closes and the agencies review the record. The DEA may proceed with scheduling as early as August 5, 2026, modify its approach, or — as in 2016 — withdraw the notice.

This page is provided for informational purposes only and does not constitute legal advice. All products sold by Favor'd Alkz are intended for adults 21 years of age or older. These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. Representative lookups use public datasets and may be imperfect where a ZIP code spans more than one district; always confirm your official on the linked government sites. Regulatory information reflects public records as of July 2026 and may change; consult primary sources at regulations.gov.

Sources: FR 2026-13580 (DEA NOI) · FR 2026-13608 (HHS RFI) · regulations.gov docket